Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NKTR Nektar Therapeutics > Detailed Quotes

NKTR Nektar Therapeutics

3.210
+0.160+5.25%
Close 09/28 16:00 ET
High
3.220
Open
3.070
Turnover
4.67M
Low
3.070
Pre Close
3.050
Volume
1.47M
Market Cap
597.94M
P/E(TTM)
Loss
52wk High
18.690
Shares
186.27M
P/E(Static)
Loss
52wk Low
3.000
Float Cap
568.52M
Bid/Ask %
0.00%
Historical High
111.360
Shs Float
177.11M
Volume Ratio
0.95
Historical Low
2.450
Dividend TTM
--
Div Yield TTM
--
P/B
1.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.83%
Amplitude
4.92%
Avg Price
3.179
Lot Size
1
Float Cap
568.52M
Bid/Ask %
0.00%
Historical High
111.360
Shs Float
177.11M
Volume Ratio
0.95
Historical Low
2.450
Dividend TTM
--
P/B
1.30
Dividend LFY
--
Turnover Ratio
0.83%
Amplitude
4.92%
Avg Price
3.179
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.
CEO: Mr. Howard W. Robin
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...